Suppr超能文献

中国南方食管鳞状细胞癌患者癌症家族史的预后影响

Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer.

作者信息

Su Zhen, Zou Guo-Rong, Mao Yan-Ping, OuYang Pu-Yun, Cao Xiao-Long, Xie Fang-Yun, Li Qun

机构信息

Panyu central hospital, Cancer Institute of Panyu, Guangzhou, China.

Department of Radiation Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.

出版信息

J Cancer. 2019 Feb 7;10(6):1349-1357. doi: 10.7150/jca.26511. eCollection 2019.

Abstract

: First degree family history of cancer is associated with developing esophageal cancer and sparse data is about the impact on poor survival among established esophageal squamous cell cancer (ESCC) patients. In this study, we investigated the prognoses of patients with ESCC with a family history. : A total of 479 ESCC patients were retrospectively enrolled from a Southern Chinese institution. A positive family history was defined as having malignant cancer among parents and siblings. Kaplan-Meier plots and Cox proportional hazards regressions were applied for overall survival (OS) and progression-free survival (PFS). : Among 479 patients, 119 (24.8%) and 68 (14.2%) reported a first-degree family history of cancer and digestive tract cancer, respectively. Compared with patients without a family history of cancer, the adjusted hazard ratios (HR) among those with it were 1.40 (95% CI, 1.08-1.82, p=0.011) for death, 1.36 (95% CI, 1.05-1.76, p=0.018) for progression. Similar results were observed in those with a family history of digestive tract cancer (HR=1.69, 95%CI, 1.24-1.98, p=0.001 for death and HR=1.77, 95%CI, 1.30-2.37, p<0.001 for progression, respectively). Furthermore, there was a trend for increasing risk of overall mortality (p=0.021, p=0.004, respectively), and progression (p=0.022, p=0.001, respectively) with an increasing number of affected family members. : A first-degree family history of cancer, especially digestive tract cancer is associated with poor survival for established ESCC patients and plays an important role in prognosis. The patients with a family history of cancer might need a greater intensity of treatment and more frequent follow-up.

摘要

癌症一级家族史与患食管癌有关,而关于其对确诊的食管鳞状细胞癌(ESCC)患者不良生存的影响的数据较少。在本研究中,我们调查了有家族史的ESCC患者的预后情况。

共从中国南方一家机构回顾性纳入了479例ESCC患者。阳性家族史定义为父母和兄弟姐妹中有恶性肿瘤。采用Kaplan-Meier曲线和Cox比例风险回归分析总生存期(OS)和无进展生存期(PFS)。

在479例患者中,分别有119例(24.8%)和68例(14.2%)报告有癌症一级家族史和消化道癌症家族史。与无癌症家族史的患者相比,有癌症家族史患者的校正风险比(HR)为死亡1.40(95%CI,1.08-1.82,p=0.011),进展1.36(95%CI,1.05-1.76,p=0.018)。在有消化道癌症家族史的患者中也观察到类似结果(死亡HR=1.69,95%CI,1.24-1.98,p=0.001;进展HR=1.77,95%CI,1.30-2.37,p<0.001)。此外,随着受影响家庭成员数量的增加,总死亡率(分别为p=0.021,p=0.004)和进展(分别为p=0.022,p=0.001)的风险有增加趋势。

癌症一级家族史,尤其是消化道癌症家族史与确诊的ESCC患者的不良生存相关,并在预后中起重要作用。有癌症家族史的患者可能需要更强的治疗强度和更频繁的随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d70/6485237/fdbe99739c77/jcav10p1349g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验